ArticlePDF Available

Assessments of Public Health and Community Organisation Responses to COVID-19 and Other Infectious Diseases by LGBTIQA People and Those Living With Blood-borne Viruses

Authors:
Assessments of public health and community
organisation responses to COVID-19 and other
infectious diseases by LGBTIQA+ people and those
living with blood-borne viruses
Research briefing paper
Kerryn Drysdale and Deborah Lupton
Suggested citation
Drysdale, K. and Lupton, D. (2023) Assessments of public health and
community organisation responses to COVID-19 and other infectious
diseases by LGBTIQA+ people and those living with blood-borne viruses.
Sydney: Vitalities Lab, UNSW Centre for Social Research in Health.
Vitalities Lab, UNSW Centre for Social Research in Health i
Acknowledgements
The researchers would like to thank the following organisations for supporting the study,
including their willingness to distribute calls for participation among their communities over
the course of the continuing COVID-19 pandemic.
ACON
Anglicare Tasmania Inc.
Hepatitis Australia
Hep B Community.org
Hepatitis South Australia
LGBTIQ+ Health Australia
LGBTI Community Ageing Network
National Association of People with HIV Australia
SAMESH
The Tasmanian Council on AIDS, Hepatitis, and Related Diseases
Working it Out, Tasmania
We are grateful to all the anonymous participants who participated in an interview.
Vitalities Lab, Centre for Social Research in Health
UNSW Sydney NSW 2052 Australia
© UNSW Sydney 2023
The Vitalities Lab, Centre for Social Research in Health, is based in the Faculty of Arts, Design and
Architecture at UNSW Sydney. This research briefing paper is an output of the ‘Diverse Experiences and
Understandings of Immunity in the Pandemic Ageresearch project, funded by UNSW as part of Deborah
Lupton’s professorial appointment research support.
Vitalities Lab, UNSW Centre for Social Research in Health 1
Abstract
This research briefing paper presents preliminary findings from the ‘Diverse Experiences
and Understandings of Immunity in the Pandemic Age’ project, conducted in 2022-2023.
The aim of this research was to identify how Australians from specific at-risk social and
community groups experience and understand the relationship between immunity and
good health in an era in which the serious risks to health posed by existing viral infections
and diseases are now joined by those from novel diseases such as COVID-19 and mpox.
Thirty semi-structured interviews were conducted with four key sub-groups: people
identifying as LGBTIQA+ and people with lived experience of HIV, hepatitis B (HBV) and
hepatitis C (HCV). These sub-groups were included in the study because they have
extensive experience in dealing with infectious disease prevention and management.
Furthermore, they are among those most at risk of further infection from other viruses. The
paper covers the participants’ responses to the question ‘How have health communication,
public health and community support initiatives helped or hindered participants’ efforts to
keep well?’. It includes recommendations for how these agencies and initiatives can better
support people and social groups faced with discrimination and socioeconomic inequalities
in the future.
Vitalities Lab, UNSW Centre for Social Research in Health 2
Overview
The aim of the ‘Diverse Experiences and Understandings of Immunity in the Pandemic
Age’ project was to identify how Australians from specific at-risk social and community
groups experience and understand the relationship between immunity and good health in
an era in which the risks posed by existing viral infections and diseases are now joined by
those from novel diseases such as COVID-19 and mpox. It is is a targeted qualitative study
seeking to capture insights from four key sub-groups of the Australian population: people
identifying as LGBTIQA+, people living with HIV, people living with hepatitis B (HBV),
and/or people with lived experience of hepatitis C (HCV)
1
. These groups are frequently
marginalised in countries such as Australia, faced with entrenched stigmatisation and
discrimination which complicates, and often impedes, their access to mainstream
healthcare. Identifying the different experiences, impacts, causes and effects among these
more marginalised, targeted and ‘hidden’ or ‘hard to reach’ populations is vital for a more
comprehensive account of how public health and community responses to emerging
infectious diseases are currently operating in Australia, and for identifying what
improvements could be made in the future.
Recent outbreaks of communicable diseases have had an unequal impact on
different population groups (Lupton, 2022; Bambra, 2022; Dionne and Turkmen, 2020),
including in Australia (Flavel and Baum, 2022). Health and sexuality status are also
contributing factors, particularly among groups who may be currently underserved by
healthcare systems and public health initiatives. Socioeconomic and health inequalities
combine with greater exposure to infection and co-infection risks for diseases such as
hepatitis, COVID and mpox (McGowan and Bambra, 2022; Mitjà et al., 2023; McKee et al.,
2018). Bambra (2022) outlined four main interconnected pathways linking inequality and
infectious disease: unequal exposure, unequal transmission, unequal susceptibility and
unequal treatment. Through these pathways, existing inequalities exacerbate the effects of
emerging infectious disease outbreaks on those groups who are already more vulnerable
to infection and reinfection, severe disease and lack of effective healthcare. Furthermore,
they are among those most at risk of further infection from other viruses, such as the novel
coronavirus that causes COVID-19, particularly in relation to Bambra’s four pathways of
inequality and transmission. At the same time, these communities have extensive
experience in dealing with infectious disease prevention and management.
There is increasing recognition of the distinct health understandings and needs of
people who have been positioned as at high risk of COVID infection: including those with
chronic health conditions, people who are immunocompromised, and those who engage
socially or sexually in close proximity to many others (Adab et al., 2022). Scientific
evidence is emerging of the complex interrelationships between immunity, existing
immunocompromise, chronic health conditions, and COVID infection and reinfection. For
example, people with pre-existing health conditions or who are immunocompromised are
at higher risk of developing severe COVID-19, long COVID and other subsequent health
problems from infection, as well as death (Lin et al., 2021; Ssentongo et al., 2021;
Hoffmann et al., 2021). COVID infection and reinfection can cause or worsen existing
1
People living with HIV, hepatitis B, and/or hepatitis C have unique experiences owing to the biomedical and
social natures of these blood-borne viruses, and therefore should not be collapsed or conflated into one
group. However, they may share intersecting characteristics, and have crossovers with broader LGBTIQA+
communities.
Vitalities Lab, UNSW Centre for Social Research in Health 3
chronic health conditions such as liver disease caused by hepatitis infection (Li et al.,
2022). Those who are already immunocompromised due to existing viral infection are at
higher risk of being infected with the mpox virus and progressing to severe disease
(Saghazadeh and Rezaei, 2023).
COVID infection can itself damage immune responses, cause damage to organs,
blood vessels and bodily systems (Parotto et al., 2023; Merad et al., 2022; Bowe et al.,
2023). Some members of the LGBTIQA+ community are at higher risk of both COVID and
mpox infection, including those who engage in frequent casual sexual contact (Prestage et
al., 2022; Philpot et al., 2021; Holt et al., 2022). People with advanced HIV infection
experience worse clinical outcomes and higher mortality if co-infected with the mpox virus
(Mitjà et al., 2023). People living with HIV and/or gay, bisexual and other men who have
sex with men have been identified as a major risk group for both COVID and mpox (May et
al., 2023; MacGibbon et al., 2023; Murphy et al., 2023; Chow et al., 2023). However, they
also often benefit from being part of communities that have a long history of successfully
engaging members in successful and inclusive risk prevention activities in response to
HIV, assisting COVID and mpox risk prevention (Murphy et al., 2023; Daroya et al., 2023;
Chow et al., 2023).
The project’s research questions are as follows:
What does the concept of ‘immunity’ mean for the participants?
Has this changed for them over their life course, and what experiences have
contributed to this change?
How does the concept of ‘immunity’ fit into their broader understandings of health or
ill-health?
What practices do they engage in to strengthen or protect their immune systems?
(e.g. vaccination, medication, infection prevention practices, general good health
practices)
How have health communication, public health and community support initiatives
helped or hindered participants’ efforts to keep well?
A total of 30 semi-structured interviews were completed by Kerryn Drysdale with
members of the four target groups between December 2022 and May 2023. The question
on which this research briefing paper focuses is: How have health communication, public
health and community support initiatives helped or hindered participants’ efforts to keep
well? Our findings contribute to better understandings of how recent major infectious
disease outbreaks have influenced these communities’ meanings and practices around
immunity, and the role played by public health and community support initiatives.
Vitalities Lab, UNSW Centre for Social Research in Health 4
Summary of key findings
Overall, the participants responded favourably to government initiatives and responses
to the COVID pandemic, particularly those offered in the early stages to prevent the
spread of the novel coronavirus SARS-CoV-2. For some participants, however, public
health orders did not go far enough, especially for those who perceived themselves as
immunocompromised or vulnerable to respiratory infections.
Participants were somewhat critical of the public health reliance on cultivating ‘personal
responsibility’ for pandemic control measures. This approach was considered
inadequate to protect more vulnerable Australians and as exacerbating existing health
inequities. Several participants described continuing discrimination and marginalisation
and called for more anti-stigma campaigns. Participants noted that the improved
accessibility of COVID-related supports was also accompanied by greater acceptability
on the part of community members. This was especially the case where such supports
were community-oriented and promoted a sense of collective responsibility for self and
others’ health.
While COVID-related public health orders and initiatives were generally perceived
favourably, there was some criticism of public health communication from government
and mainstream health services. For example, participants noted the need for better
accessibility for health-related information to ensure that ‘information gets out’.
Participants felt that there was an integral role for community organisations to play in
relation to providing support and connection. While COVID-related public health orders
and initiatives were generally perceived favourably, there was some criticism of public
health communication from government and mainstream health services. In response,
some participants felt that government and public health should ‘hand over’ complex
health information and messaging to community organisations, as they are able to
‘properly tailor’ such messages.
In relation to other health concerns, participants called for more subsidies in and better
access to health services. Trans and gender diverse people criticised the delays in
gender affirming care caused by the pandemic. Participants also recommended new or
alternative healthcare measures that focused on preventive health. Acknowledging the
importance of strong personal data privacy and security protections, participants called
for better tools to track/record and access to their health history, as well as automated
reminder systems for upcoming vaccinations.
Beyond healthcare services, community organisations were seen as providing a
valuable interface between a largely faceless public health system and the community.
Participants felt that there was an integral role for community organisations to play in
relation to providing support and connection. However, for some participants there was
an increased perception of potential disenfranchisement from community
organisations.
Finding ways for public health agencies and health communication campaign
managers to work more closely and productively with trusted community organisations
would strengthen prevention and education initiatives for COVID and other infectious
disease prevention and treatment. Expanding free or low-cost healthcare for
marginalised groups, including better information about and access to vaccines, would
improve health promotion in these communities.
Vitalities Lab, UNSW Centre for Social Research in Health 5
Methods
The ‘Diverse Experiences and Understandings of Immunity in the Pandemic Age’ study
received approval from the UNSW Human Research Ethics Committee (HC220677) and
from ACON’s Research Ethics Review Committee (RERC202225). Letters of support for
research provided by peak representative organisations Hepatitis Australia, Hep B
Community, The National Association of People with HIV Australia, and LGBTIQ+ Health
Australia. Participants were recruited to the study though both public facing (e.g., social
media) and closed (e.g., email lists) advertisements by organisations who represented
these distinctive, but often intersecting, sub-populations. The recruitment strategy used
was underscored by the recognition that strong community ties and advocacy has been
successful in managing past infectious diseases, and accordingly, representative
organisational support was key to recruitment among these communities (Drysdale et al.,
2023). Participants were eligible to participate if they self-identified as belonging to one or
more of the target groups and were aged 18+ years of age and living in Australia. All
participants provided informed consent (written or verbal) prior to the interview and were
thanked for their time with a $50AUD e-voucher.
Purposive sampling and screening ensured participant diversity in age, gender,
ethnicity/race and geographical location. Table 1 (Appendix) provides the
sociodemographic details of the participants. They ranged in age from 20 to 68 years of
age. There was inclusive gender distribution among cis and trans men and woman, and
non-binary people, and inclusive sexuality distribution among heterosexual, gay/lesbian,
bisexual and other identities. The proportion of participants living in regional or rural areas,
born in other countries, and speaking languages other than English also make this sample
diverse.
The following questions were asked in the interview:
Please describe to me how well you feel today? (e.g., great health, weak or poor
health, a bit sick, really sick etc.) What is causing this state of health/illness for you
right now? (e.g. current infection, rundown from past infections, engaging in health
promoting behaviours such as eating well etc.) How does this relate to your
experience of transmissible respiratory and/or close contact infections (COVID,
mpox etc)?
Please tell me about illnesses and infections you have experienced over your
lifetime (as much as you can remember). How old were you at the time, how sick
did you feel, what helped you recover, have you had any long-lasting effects or
medication needed since then?
Please tell me about any vaccinations you have had over your life. What were they
for?
Please tell me how you feel about vaccines in general? (e.g., strong support, weak
support, ambivalent, anti-vax). Please explain your position on vaccines? Did you
feelings change at any point along your life course?
How would you describe your state of immunity to infectious diseases right now?
(e.g., would you describe it as ‘poor’, ‘weak’, ‘strong’ etc?) What aspects of your life
have influenced this state of your immunity, do you think?
Do you think there’s anything that the government, public health or the medical
profession can do to improve your state of immunity and general health state right
now?
What about community organisations? Have they helped? In what ways can they
help in the future?
Vitalities Lab, UNSW Centre for Social Research in Health 6
Is there anything else you would like to say about the topics we’ve just discussed?
Of the 30 interviews, 27 were conducted via video conferencing to enhance
accessibility and COVID safety. The other three interviews were conducted face-to-face in
local needle and syringe exchanges as preferred by these participants. The interviews
ranged in length between 28 to 50 minutes. A timeline was constructed (hand drawn by
Kerryn Drysdale), as participants responded to the questions, generating a chronological
biographical record of participants’ illnesses, infections and vaccination experiences over
their lives to date, and serving as prompts to ask more detailed questions about periods of
health or ill health over participants’ life courses.
Findings
Accessibility and acceptability of public health initiatives
“I think it’s a difficult situation, because it is a situation where I believe the
majority would prefer not to be following [COVID protections]. And because it’s
the majority that don’t feel like they are going to be as affected. But if you have
people with disabilities or who have compromised immune systems, like they are
the people and the families of those people who would want protections. … And I
feel like the people in the majority who would not want to wear masks and stuff
would feel like personally slighted against for having to follow health
recommendations, which would actually, like, save the lives of people.”
Overall, participants responded favourably to government initiatives and responses to the
COVID pandemic, particularly those that were offered in the early stages to prevent the
spread of the virus. There was broad support of mask wearing mandates, temporary lock
downs, and vaccination rollouts. Free access to COVID-related supports were also
considered beneficial to maintaining good health. These included ready access to
respiratory clinics and vaccinations as well as the temporary expansion of allied health
services, such as increased sessions under Medicare-subsidised mental health plans, as
well as improved avenues for accessing healthcare, including services that did not require
Medicare cards.
For some participants, however, public health orders did not go far enough,
especially for those who perceived themselves as immunocompromised or vulnerable to
respiratory infection. For instance, some participants believed that the mask mandates
were lifted too soon or were not uniformly enforced, and so Australia missed the
opportunity to develop a strong mask-wearing culture such as that evident in some East
Asian countries. Other participants felt that government may have capitulated too early, or
have been too reactive, to negative press around mask mandates. While lockdowns were,
on the whole, viewed favourably as necessary to prevent the spread of infection, criticism
of made of the lack of wrap around supports, such as housing provision and financial
support, that were perceived to be absent during periods of lockdowns. Two participants
were also highly critical of state government decisions to reopen schools, highlighting the
risk of infection faced by teachers and students.
In relation to other health concerns, participants called for more subsidies in and
better access to health services. They suggested making HIV antiretroviral drugs free for
all people living with HIV and increased rebates for other healthcare services in Medicare.
Vitalities Lab, UNSW Centre for Social Research in Health 7
Participants suggested that the expansion of mental health plan sessions, pharmacies
dispensing medicines and better bulk billing opportunities/access, better opportunities for
those working traditional work hours to access vaccination clinics and healthcare, and
more generalist healthcare access (as compared to specialist care that was perceived to
be more accessible but more costly) would greatly contribute to protecting and maintaining
good health in their communities. Trans and gender diverse people were especially critical
of delays in gender affirming care caused by the COVID pandemic. There was a clear
demand for more gender affirmation subsidies in healthcare, especially for those who
wanted to medically affirm their gender.
The implementation of telehealth in the early stages of COVID was seen as highly
positive. However, one participant who lived in a rural location pointed to the new levels of
COVID infection risk they faced: despite the accessibility of telehealth, they still needed
trips to the pharmacy to pick up their medications. Participants also recommended new or
alternative healthcare measures that focused on preventive health. These suggestions
included better streamlining of S100 prescribers and sexual health, better healthcare
access and support for Aboriginal and Torres Strait Islander peoples, and incentives for
people from stigmatised or marginalised communities to take better care of their health,
such as people who use illicit or recreational drugs. For some people living with HIV,
Australia’s HIV prevention and treatment programs served as a good model for future
integrated healthcare and public health responses. One participant specifically highlighted
prison link-up services as another model that could be adapted to support other
populations or diseases.
The relative visibility and use of the Australian Immunisation Register during the
COVID vaccination rollout was viewed as ensuring easy access to vaccination information.
However, several participants wished that all information on individuals’ vaccinations from
birth should be as easily accessible. Often participants did not recall all the vaccinations
through their life course other than a belief that they must have had ‘all the usual childhood
vaccinations’. The difficulty of recollection was also exacerbated by different ‘service app’
requirements and availability in different state jurisdictions (with different access to
immunisation registers).
Acknowledging the importance of strong personal data privacy and security
protections, participants called for better tools to track/record and access health history, as
well as automated reminder systems for upcoming vaccinations. The government’s
electronic health record My Health Record rarely came up in interviews as a way of
keeping health records that people could refer to throughout their lives, suggesting either
that this initiative has not been well advertised to the community or is being actively
shunned.
Connection and support
“So one of the things I think that people learnt about [the AIDS response] is you
have to temper the message. You can’t sort of wag your finger and say ‘No, you
must not have sex.’ Because that just sounds too preachy and people are just
going to rebel against that – especially gay men who may have this history of
being repressed and being, you know, ostracised. So it just needs to be more,
‘What’s in it for me, what’s the win-win in doing this?’
Participants noted that the improved accessibility of COVID-related supports was also
accompanied by greater acceptability on the part of community members. This was
Vitalities Lab, UNSW Centre for Social Research in Health 8
especially the case where such supports were community-oriented and promoted a sense
of collective responsibility for self and others’ health. Respiratory clinics, for instance, were
seen as helpful beyond the healthcare that they offered; they were also seen as a version
of community support, and there was a demand for more of them.
Participants were somewhat critical of the public health reliance on cultivating
‘personal responsibility’ for pandemic control measures, as this was seen as inadequate as
a protection for more vulnerable Australians. This approach was perceived to create
divisions between those who care about the health of others and so do the ‘right thing’
compared to those who wanted a swift return to ‘normal’. Participants noted that this
division exacerbated existing health inequities. They spoke of new divides between most
Australians in good health versus those living with disabilities or chronic health conditions;
between various states with differing public health orders, such as between Victoria and
New South Wales; and between those who resided in ‘fortressed’ states, such as Western
Australia, compared with the rest of the nation.
Several participants spoke of continuing discrimination and marginalisation and
called for more anti-stigma campaigns. Particularly for people living with HIV and those
living with HBV, stigma about their conditions had continued during the COVID pandemic.
For people living with or affected by HCV, participants residing outside the populous capital
cities in the eastern seaboard felt that the ‘small town’ syndrome, where everyone knows
each other or are tightly networked, inhibited their access to targeted treatment due to lack
of anonymity.
It was common for people to emphasise that there was an integral role for
community organisations to play in relation to providing support and connection as well as
providing services such as information and vaccinations. In particular, participants
highlighted how community organisations promote and maintain a caring ‘ethos’ towards
their community, evident by the numbers of people volunteering in these organisations.
This extended to the support provided by community organisations, some of which kept
open ‘drop in spaces’ which were perceived to be a great source of support and
connection during COVID lockdowns. The perception of community support was amplified
through the consistent social media presence (for example, their Instagram and Facebook
accounts) that some community organisations maintained during the early phases of the
pandemic.
AIDS Councils were seen as serving a wider community beyond those living with
HIV, drawing on their knowledge of how to sensitively engage community members in
ways that were non-judgemental and aware of community needs: for example, in relation
to the prevention of mpox through education and vaccination provision. ACON in particular
was specified as an important source of mental health support for those who were unable
to access support services through mainstream health systems.
Beyond healthcare, community organisations were seen by many to serve as the
interface between a largely faceless public health system and community. Here again
ACON was singled out as taking the lead nationally over other state-based organisations.
For people living with HBV, forums like the Hep B Community site were seen as sites of
non-judgement, a credible source of information and the promotion of a sense of
community among those who felt stigmatised or disenfranchised by mainstream services.
The use of bilingual culturally and linguistically diverse community workers for HBV were
seen as a strong source of support, similar to sentiment expressed for HIV-sector peer
navigators.
However, there was an increased perception of potential disenfranchisement from
community organisations. For example, this can occur when an individual has a negative
interaction with a community organisation, is ‘ejected from community spaces’ or ‘chewed
up and spat out’ in volunteering roles. One participant termed this an issue with ‘lateral
Vitalities Lab, UNSW Centre for Social Research in Health 9
violence’ within the LGBTIQA+ community. While a minority of participants pointed to
interpersonal dynamics in close-knit community groups, more held concerns around a lack
of current representation in organisations more generally (that is, too many cisgender gay
men), alongside recognition that such organisations cannot possibly represent all
experiences and identities (for example, a bisexual Aboriginal man is likely to feel a lack of
representation in community-run services). These problems were recognised as partially
owing to a lack of secure, permanent funding, a reliance on volunteer labour, being too
urban/city centric, and having too much focus on HIV prevention than the need for promote
social connection and, for one participant, a lack of cancer-related attention.
Public health communication and education
“A community like ACON can help, I think, separate the overwhelming
information. You know, because you have expert A on the ABC, you have expert
B on at Channel 7, you have expert C on Channel 9, sort of saying different
things, and then you have the government medical officers. I think an
organisation like ACON can say, ‘Well, we have taken all this and based on our
medical experts, we think this is the approach to take.’ And I think those types of
organisations are probably better placed to give advice that the community will
listen to – rather than, you know, different information from different sources and
different people. So that’s probably where I think it could be better done.”
While COVID-related public health orders and initiatives were generally perceived
favourably, there was some criticism of public health communication from government and
mainstream health services. For example, participants noted the need for better
accessibility for health-related information to ensure that ‘information gets out’. This lack of
accessibility is also complicated by what was perceived to be a lack of consistent
messaging regarding COVID risk and precautions that could be taken. This was especially
the case for participants from culturally and linguistically diverse backgrounds, who
commented on the ‘muddled’ messaging around COVID vaccination types and eligibility.
While the provision of COVID information was initially detailed and frequent, participants
noted that there was an increasingly lack of availability of details such as case numbers
over time, leading to the perception of declining public interest in COVID safe precautions
Some participants felt that this was due to a lack of visible respect in public forums for
‘scientists’.
In response, some participants felt that government and public health should ‘hand
over’ complex health information and messaging to community organisations, as they are
able to ‘properly tailor’ such messages. Targeted, non-stigmatising advice that builds on
LGBTIQA+ strengths was seen to be a role for community organisations. Such advice
extends beyond the provision of COVID- or mpox-related information to sharing details
about good experiences with allied healthcare, such as the circulation of information on
LGBTIQA+ friendly services. The idea was that health information should be ‘marketed by
community’ but ‘funded by government’. Participants noted that using community or social
events to distribute health information was a key strength of community organisations’
communication strategies. Community-led campaigns resonate because ACON,
especially, uses ‘real people’ in their campaigns and depend on the role of peers to
disseminate information effectively. Participants felt that community organisations also
shared practical, yet non-alarmist, information on mpox.
Vitalities Lab, UNSW Centre for Social Research in Health 10
Despite the value of community-based information circulation, participants pointed
to strategies for improvement. Their suggestions included community organisations
needing to be more proactive in sifting through and distilling relevant information. People
noted that resources can be hard to find they do not know where to look on websites and
other information sources. Specifically, for those people living with HBV, there was
generally broad support for government and public health initiatives over increasing
awareness of accessibility of vaccinations, referral pathways to specialists, and free liver
scans. Free and broad access to annual flu vaccines was also considered beneficial to
good management of HBV symptomology and general good health. However, among
these participants, there was recognition that HBV information and education around
specific lifestyle recommendations and the availability of HBV vaccinations was lacking
(‘unnoticed’) among the general public.
Recommendations
The members of the LGBTIQA+ community and people with lived experience of blood-
borne viruses who participated in our study offered strong and helpful suggestions for how
public health authorities and community organisations can work together to improve public
health communication and services related to COVID-19, mpox, hepatitis, HIV, AIDS and
other infections and communicable diseases. Returning to Bambra’s (2022) pathways
linking inequality and infectious disease (unequal exposure, unequal transmission, unequal
susceptibility and unequal treatment), our participants’ responses highlight how successful
interactions between health communication strategies, inclusive health service delivery,
social supports and public health protections, together with community organisations’
services, education campaigns and other supports, can alleviate the impacts of these
inequalities.
Health communication and healthcare services that recognise cultural and health
diversity and offer clear, regular and updated advice that is non-judgemental and inclusive
are highly important. Community organisations that recognise the diversity within their
organisation membership and can focus on education and prevention related to the
continuing COVID risks as well as the infectious diseases and other health risks with which
they were more familiar offer the most helpful support. Finding ways for public health
agencies and health communication campaign managers to work more closely and
productively with trusted community organisations would strengthen prevention and
education initiatives for COVID and other infectious disease prevention and treatment.
Expanding free or low-cost healthcare for marginalised groups, including better information
about and access to vaccines, would improve health promotion in these communities.
Vitalities Lab, UNSW Centre for Social Research in Health 11
References
Adab P, Haroon S, O’Hara ME, et al. (2022) Comorbidities and COVID-19. British Medical Journal,
377. https://www.bmj.com/content/377/bmj.o1431.short
Bambra C (2022) Pandemic inequalities: emerging infectious diseases and health equity.
International Journal for Equity in Health, 21.
https://link.springer.com/article/10.1186/s12939-021-01611-2
Bowe B, Xie Y and Al-Aly Z (2023) Postacute sequelae of COVID-19 at 2 years. Nature Medicine
29(9): 2347-2357.
Chow EPF, Samra RS, Bradshaw CS, et al. (2023) Mpox knowledge, vaccination and intention to
reduce sexual risk practices among men who have sex with men and transgender people in
response to the 2022 mpox outbreak: a cross-sectional study in Victoria, Australia. Sexual
Health 20(5): 390-402.
Daroya E, Grey C, Lessard D, et al. (2023) ‘I did not have sex outside of our bubble’: changes in
sexual practices and risk reduction strategies among sexual minority men in Canada during
the COVID-19 pandemic. Culture, Health & Sexuality 25(9): 1147-1163.
Dionne KY and Turkmen FF (2020) The politics of pandemic othering: putting COVID-19 in global
and historical context. International Organization 74(S1): E213-E230.
Drysdale K, Wells N, Smith AK, et al. (2023) Beyond the challenge to research integrity: imposter
participation in incentivised qualitative research and its impact on community engagement.
Health Sociology Review 32(3): 372-380.
Flavel J and Baum F (2022) The influence of socioeconomic conditions on the epidemiology of
COVID19 in Australia. The Medical Journal of Australia 216(7): 344-345.
Hoffmann C, Casado JL, Härter G, et al. (2021) Immune deficiency is a risk factor for severe
COVID19 in people living with HIV. HIV Medicine 22(5): 372-378.
Holt M, MacGibbon J, Bavinton B, et al. (2022) COVID-19 vaccination uptake and hesitancy in a
national sample of Australian gay and bisexual men. AIDS and Behavior 26(8): 2531-2538.
Li P, Liu Y, Cheng Z, et al. (2022) COVID-19-associated liver injury: clinical characteristics,
pathophysiological mechanisms and treatment management. Biomedicine &
Pharmacotherapy, 154. https://doi.org/10.1016/j.biopha.2022.113568
Lin Y, Yuan J, Long Q, et al. (2021) Patients with SARS-CoV-2 and HBV co-infection are at risk of
greater liver injury. Genes & Diseases 8(4): 484-492.
Lupton D (2022) COVID Societies: Theorising the Coronavirus Crisis. Abingdon: Routledge.
MacGibbon J, Cornelisse VJ, Smith AK, et al. (2023) Mpox (monkeypox) knowledge, concern,
willingness to change behaviour, and seek vaccination: results of a national cross-sectional
survey. Sexual Health 20(5): 403-410.
May T, Towler L, Smith LE, et al. (2023) Mpox knowledge, behaviours and barriers to public health
measures among gay, bisexual and other men who have sex with men in the UK: a
qualitative study to inform public health guidance and messaging. BMC Public Health, 23.
https://doi.org/10.1186/s12889-023-17196-0
McGowan VJ and Bambra C (2022) COVID-19 mortality and deprivation: pandemic, syndemic, and
endemic health inequalities. The Lancet Public Health, 7. https://doi.org/10.1016/S2468-
2667(22)00223-7
McKee G, Butt ZA, Wong S, et al. (2018) Syndemic characterization of HCV, HBV, and HIV co-
infections in a large population based cohort study. eClinicalMedicine 4: 99-108.
Merad M, Blish CA, Sallusto F, et al. (2022) The immunology and immunopathology of COVID-19.
Science 375(6585): 1122-1127.
Mitjà O, Alemany A, Marks M, et al. (2023) Mpox in people with advanced HIV infection: a global
case series. The Lancet 401(10380): 939-949.
Murphy D, Ellard J, Maher L, et al. (2023) How to have sex in a pandemic: the development of
strategies to prevent COVID-19 transmission in sexual encounters among gay and bisexual
men in Australia. Culture, Health & Sexuality 25(3): 271-286.
Parotto M, Gyöngyösi M, Howe K, et al. (2023) Post-acute sequelae of COVID-19: understanding
and addressing the burden of multisystem manifestations. The Lancet Respiratory Medicine
11(8): 739-754.
Vitalities Lab, UNSW Centre for Social Research in Health 12
Philpot SP, Holt M, Murphy D, et al. (2021) Qualitative findings on the impact of COVID-19
restrictions on Australian gay and bisexual men: community belonging and mental well-
being. Qualitative Health Research, 31(13): 2414-2425.
Prestage G, Storer D, Jin F, et al. (2022) COVID-19 vaccine uptake and its impacts in a cohort of
gay and bisexual men in Australia. AIDS and Behavior 26(8): 2692-2702.
Saghazadeh A and Rezaei N (2023) Insights on Mpox virus infection immunopathogenesis.
Reviews in Medical Virology, 33. https://doi.org/10.1002/rmv.2426
Ssentongo P, Heilbrunn ES, Ssentongo AE, et al. (2021) Epidemiology and outcomes of COVID-19
in HIV-infected individuals: a systematic review and meta-analysis. Scientific Reports, 11.
https://www.nature.com/articles/s41598-021-85359-3
Vitalities Lab, UNSW Centre for Social Research in Health 13
Appendix: Sociodemographic details of participants
Characteristics
Total (n=30)
Age
20-29 years
30-39 years
40-49 years
50-59 years
60-69 years
6 (20%)
9 (30%)
5 (17%)
7 (23%)
3 (10%)
Gender
Man (cis and trans)
Woman (cis and trans)
Non-binary
14 (47%)
11 (37%)
5 (17%)
Sexuality
Heterosexual
Gay
Lesbian
Bisexual
Queer
Another term
4 (13%)
10 (33%)
2 (7%)
4 (13%)
6 (20%)
4 (13%)
Indigenous status
Aboriginal and/or Torres Strait Islander
Not Indigenous
2 (7%)
28 (93%)
Blood borne virus status*
HIV
HBV
HCV
No BBV
*Categories not mutually exclusive
8 (27%)
2 (7%)
7 (23%)
15 (50%)
Country of birth
Australia
Other
20 (67%)
10 (33%)
Language spoken at home
English
Other
24 (80%)
6 (20%)
State of residence
Australian Capital Territory
New South Wales
Queensland
South Australia
Tasmania
Victoria
Western Australia
1 (3%)
14 (47%)
3 (10%)
2 (7%)
4 (13%)
4 (13%)
2 (7%)
Location of residence
Urban
Regional
Rural
24 (80%)
4 (13%)
2 (7%)
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background The 2022-23 mpox epidemic is the first-time sustained community transmission had been reported in countries without epidemiological links to endemic areas. During that period, the outbreak almost exclusively affected sexual networks of gay, bisexual, or other men who have sex with men (GBMSM) and people living with HIV. In efforts to control transmission, multiple public health measures were implemented, including vaccination, contact tracing and isolation. This study examines knowledge, attitudes, and perceptions of mpox among a sample of GBMSM during the 2022-23 outbreak in the UK, including facilitators for and barriers to the uptake of public health measures. Methods Interviews were conducted with 44 GBMSM between May and December 2022. Data were analysed using reflexive thematic analysis. Positive and negative comments pertaining to public health measures were collated in a modified version of a ‘table of changes’ to inform optimisations to public health messages and guidance. Results Most interviewees were well informed about mpox transmission mechanisms and were either willing to or currently adhering to public health measures, despite low perceptions of mpox severity. Measures that aligned with existing sexual health practices and norms were considered most acceptable. Connections to GBMSM networks and social media channels were found to increase exposure to sexual health information and norms influencing protective behaviours. Those excluded or marginalized from these networks found some measures challenging to perform or adhere to. Although social media was a key mode of information sharing, there were preferences for timely information from official sources to dispel exaggerated or misleading information. Conclusions There are differential needs, preferences, and experiences of GBMSM that limit the acceptability of some mitigation and prevention measures. Future public health interventions and campaigns should be co-designed in consultation with key groups and communities to ensure greater acceptability and credibility in different contexts and communities.
Article
Full-text available
Background In mid-2022, a global mpox (formerly ‘monkeypox’) outbreak affecting predominantly gay and bisexual men emerged in non-endemic countries. Australia had never previously recorded mpox cases and there was no prior research on knowledge or attitudes to mpox among gay and bisexual men across Australia. Methods We conducted a national, online cross-sectional survey between August 2022 and September 2022. Participants were recruited through community organisation promotions, online advertising, and direct email invitations. Eligible participants were gay, bisexual or queer; identified as male (cisgender or transgender) or non-binary; aged 16 years or older; and lived in Australia. The main outcome measures were: knowledge and concern about mpox; recognition of mpox symptoms and transmission routes; vaccination history; acceptability of behavioural changes to reduce mpox risk, and willingness to be vaccinated. Results Of 2287 participants, most participants were male (2189/2287; 95.7%) and gay (1894/2287; 82.8%). Nearly all had heard about mpox (2255/2287; 98.6%), and the majority were concerned about acquiring it (1461/2287; 64.4%). Most of the 2268 participants not previously diagnosed with mpox correctly identified skin lesions (2087; 92%), rash (1977; 87.2%), and fever (1647; 72.6%) as potential symptoms, and prolonged and brief skin-to-skin contact as potential ways to acquire mpox (2124, 93.7%; and 1860, 82%, respectively). The most acceptable behavioural changes were reducing or avoiding attendance at sex parties (1494; 65.9%) and sex-on-premises venues (1503; 66.4%), and having fewer sexual partners (1466; 64.6%). Most unvaccinated and undiagnosed participants were willing to be vaccinated (1457/1733; 84.1%). Conclusions People at risk of mpox should be supported to adopt acceptable risk reduction strategies during outbreaks and to seek vaccination.
Article
Full-text available
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to postacute sequelae in multiple organ systems, but evidence is mostly limited to the first year postinfection. We built a cohort of 138,818 individuals with SARS-CoV-2 infection and 5,985,227 noninfected control group from the US Department of Veterans Affairs and followed them for 2 years to estimate the risks of death and 80 prespecified postacute sequelae of COVID-19 (PASC) according to care setting during the acute phase of infection. The increased risk of death was not significant beyond 6 months after infection among nonhospitalized but remained significantly elevated through the 2 years in hospitalized individuals. Within the 80 prespecified sequelae, 69% and 35% of them became not significant at 2 years after infection among nonhospitalized and hospitalized individuals, respectively. Cumulatively at 2 years, PASC contributed 80.4 (95% confidence interval (CI): 71.6–89.6) and 642.8 (95% CI: 596.9–689.3) disability-adjusted life years (DALYs) per 1,000 persons among nonhospitalized and hospitalized individuals; 25.3% (18.9–31.0%) and 21.3% (18.2–24.5%) of the cumulative 2-year DALYs in nonhospitalized and hospitalized were from the second year. In sum, while risks of many sequelae declined 2 years after infection, the substantial cumulative burden of health loss due to PASC calls for attention to the care needs of people with long-term health effects due to SARS-CoV-2 infection.
Article
Full-text available
Background The first mpox case was reported in May 2022 in Australia. Most cases have been diagnosed in men who have sex with men (MSM). This study aimed to examine community understanding of mpox, attitudes towards vaccination, and potential changes in sexual practices surrounding the mpox outbreak among MSM and transgender people in Victoria, Australia. Methods Participants were recruited from sexual health clinics and communities in Victoria, Australia, in August–October 2022. Participants were asked about their understanding and knowledge of mpox, vaccination uptake and intentions to change sexual practices. Univariable and multivariable logistic regression was performed to examine the factors associated with mpox vaccine uptake. Results Most participants (97.8%, 525/537) had heard about mpox and 10.5% (55/525) knew someone who had had mpox. Of the 12 mpox knowledge questions, the median score of correct answers was 10 (IQR = 8–11) out of a maximum of 12. More than a third (36.6%, 191/522) had been vaccinated against mpox. MSM who had a good knowledge of mpox had the highest odds of receiving mpox vaccine compared with those who had poor knowledge (aOR = 4.05; 95% CI: 1.54–10.61). To prevent mpox, half reported they would reduce having sex with casual partners, stop having chemsex (used drugs for the purpose of sex), stop attending sex-on-premises-venues, and stop having group sex. A quarter reported they would increase condom use for anal sex. Conclusions One-third of high-risk participants and a substantial proportion of participants intended to reduce or stop certain practices, which may explain the large reduction in mpox cases.
Article
Full-text available
In efforts to prevent the spread of COVID-19, jurisdictions across the globe, including Canada, enacted containment measures that affected intimacy and sexual relations. This article examines how public health measures during COVID-19 impacted the sexual practices of sexual minority men- gay, bisexual, queer and other men who have sex with men-and how they adopted and modified guidelines to prevent the transmission of COVID-19, HIV and other sexually transmitted infections (STIs). We conducted 93 semi-structured interviews with men (n = 93) in Montreal, Toronto and Vancouver, Canada, between November 2020 to February 2021 (n = 42) and June to October 2021 (n = 51). Across jurisdictions, participants reported changes to sexual practices in response to public health measures and shifting pandemic contexts. Many men indicated that they applied their HIV/STI risk mitigation experiences and adapted COVID-19 prevention strategies to continue engaging in casual sexual behaviours and ensure sexual safety. 'Social bubbles' were changed to 'sex bubbles'. Masks were turned into 'safer' sex tools. 'Outdoor gathering' and 'physical distancing' were transformed into 'outdoor sex' and 'voyeuristic masturbation'. These strategies are examined in connection to the notion of 'reflexive mediation' to illustrate how sexual minority men are simultaneously self-responsibilising and resistant, self-monitoring and creative.
Article
Full-text available
COVID-19 has exacerbated endemic health inequalities resulting in a syndemic pandemic of higher mortality and morbidity rates among the most socially disadvantaged. We did a scoping review to identify and synthesise published evidence on geographical inequalities in COVID-19 mortality rates globally. We included peer-reviewed studies, from any country, written in English that showed any area-level (eg, neighbourhood, town, city, municipality, or region) inequalities in mortality by socioeconomic deprivation (ie, measured via indices of multiple deprivation: the percentage of people living in poverty or proxy factors including the Gini coefficient, employment rates, or housing tenure). 95 papers from five WHO global regions were included in the final synthesis. A large majority of the studies (n=86) found that COVID-19 mortality rates were higher in areas of socioeconomic disadvantage than in affluent areas. The subsequent discussion reflects on how the unequal nature of the pandemic has resulted from a syndemic of COVID-19 and endemic inequalities in chronic disease burden.
Article
Participant recruitment for qualitative research often offers incentives (honoraria; financial compensation) to increase participation and to recognise lived expertise and time involved in research. While not necessarily a new concern for survey and other quantitative based research, ‘spam', ‘bot', and other inauthentic forms of research participation has rarely been an apparent issue for qualitative research, given it often involves levels of interaction with potential participants prior to the conduct of in-depth interviews and other methods of data generation. This is no longer the case. A troubling new occurrence has meant that recruitment calls for qualitative research with incentives on public-facing social media have attracted ‘imposter’ expressions of interest and research participation. In this commentary, we explore this challenge that goes beyond research integrity. In particular, we consider the risks of employing strategies to screen for legitimate participants and the importance of building trust and maintaining community engagement.
Article
Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after the initial acute illness. The post-acute sequelae of COVID-19, which include physical, cognitive, and mental health impairments, are known collectively as long COVID or post-COVID-19 condition. The substantial burden of this multisystem condition is felt at individual, health-care system, and socioeconomic levels, on an unprecedented scale. Survivors of COVID-19-related critical illness are at risk of the well known sequelae of acute respiratory distress syndrome, sepsis, and chronic critical illness, and these multidimensional morbidities might be difficult to differentiate from the specific effects of SARS-CoV-2 and COVID-19. We provide an overview of the manifestations of post-COVID-19 condition after critical illness in adults. We explore the effects on various organ systems, describe potential pathophysiological mechanisms, and consider the challenges of providing clinical care and support for survivors of critical illness with multisystem manifestations. Research is needed to reduce the incidence of post-acute sequelae of COVID-19-related critical illness and to optimise therapeutic and rehabilitative care and support for patients.
Article
Background: People living with HIV have accounted for 38-50% of those affected in the 2022 multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell counts and similar outcomes to those without HIV. Emerging data suggest worse clinical outcomes and higher mortality in people with more advanced HIV. We describe the clinical characteristics and outcomes of mpox in a cohort of people with HIV and low CD4 cell counts (CD4 <350 cells per mm3). Methods: A network of clinicians from 19 countries provided data of confirmed mpox cases between May 11, 2022, and Jan 18, 2023, in people with HIV infection. Contributing centres completed deidentified structured case report sheets to include variables of interest relevant to people living with HIV and to capture more severe outcomes. We restricted this series to include only adults older than 18 years living with HIV and with a CD4 cell count of less than 350 cells per mm3 or, in settings where a CD4 count was not always routinely available, an HIV infection clinically classified as US Centers for Disease Control and Prevention stage C. We describe their clinical presentation, complications, and causes of death. Analyses were descriptive. Findings: We included data of 382 cases: 367 cisgender men, four cisgender women, and ten transgender women. The median age of individuals included was 35 (IQR 30-43) years. At mpox diagnosis, 349 (91%) individuals were known to be living with HIV; 228 (65%) of 349 adherent to antiretroviral therapy (ART); 32 (8%) of 382 had a concurrent opportunistic illness. The median CD4 cell count was 211 (IQR 117-291) cells per mm3, with 85 (22%) individuals with CD4 cell counts of less than 100 cells per mm3 and 94 (25%) with 100-200 cells per mm3. Overall, 193 (51%) of 382 had undetectable viral load. Severe complications were more common in people with a CD4 cell count of less than 100 cells per mm3 than in those with more than 300 cells per mm3, including necrotising skin lesions (54% vs 7%), lung involvement (29% vs 0%) occasionally with nodules, and secondary infections and sepsis (44% vs 9%). Overall, 107 (28%) of 382 were hospitalised, of whom 27 (25%) died. All deaths occurred in people with CD4 counts of less than 200 cells per mm3. Among people with CD4 counts of less than 200 cells per mm3, more deaths occurred in those with high HIV viral load. An immune reconstitution inflammatory syndrome to mpox was suspected in 21 (25%) of 85 people initiated or re-initiated on ART, of whom 12 (57%) of 21 died. 62 (16%) of 382 received tecovirimat and seven (2%) received cidofovir or brincidofovir. Three individuals had laboratory confirmation of tecovirimat resistance. Interpretation: A severe necrotising form of mpox in the context of advanced immunosuppression appears to behave like an AIDS-defining condition, with a high prevalence of fulminant dermatological and systemic manifestations and death. Funding: None.
Article
An immunocompromised status has been associated with more odds of being infected with monkeypox virus (MPXV) and progressing to severe disease. This aligns with the importance of immune competence for MPXV control and clearance. We and others have previously reviewed parallels between MPXV and other viruses belonging to the Poxviridae in affecting the immune system. This article reviews studies providing direct evidence of the MPXV-immune interactions. The wide-ranging effects of MPXV on the immune system, from stimulation to modulation to memory, are broadly categorised, followed by a detailing of these effects on the immune cells and molecules, including natural killer cells, macrophages, neutrophils, lymphocytes, cytokines, interferons, chemokines, and complement.